1. Home
  2. PSN vs RGEN Comparison

PSN vs RGEN Comparison

Compare PSN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSN
  • RGEN
  • Stock Information
  • Founded
  • PSN 1944
  • RGEN 1981
  • Country
  • PSN United States
  • RGEN United States
  • Employees
  • PSN N/A
  • RGEN N/A
  • Industry
  • PSN EDP Services
  • RGEN Medical/Dental Instruments
  • Sector
  • PSN Technology
  • RGEN Health Care
  • Exchange
  • PSN Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • PSN 7.8B
  • RGEN 8.0B
  • IPO Year
  • PSN 2019
  • RGEN N/A
  • Fundamental
  • Price
  • PSN $65.43
  • RGEN $132.44
  • Analyst Decision
  • PSN Buy
  • RGEN Buy
  • Analyst Count
  • PSN 11
  • RGEN 12
  • Target Price
  • PSN $87.44
  • RGEN $172.67
  • AVG Volume (30 Days)
  • PSN 1.4M
  • RGEN 863.9K
  • Earning Date
  • PSN 04-30-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • PSN N/A
  • RGEN N/A
  • EPS Growth
  • PSN 50.29
  • RGEN N/A
  • EPS
  • PSN 2.35
  • RGEN N/A
  • Revenue
  • PSN $6,769,260,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • PSN $5.09
  • RGEN $13.93
  • Revenue Next Year
  • PSN $4.47
  • RGEN $14.35
  • P/E Ratio
  • PSN $27.69
  • RGEN N/A
  • Revenue Growth
  • PSN 16.61
  • RGEN 4.88
  • 52 Week Low
  • PSN $54.56
  • RGEN $102.97
  • 52 Week High
  • PSN $114.68
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • PSN 53.87
  • RGEN 49.67
  • Support Level
  • PSN $63.07
  • RGEN $123.10
  • Resistance Level
  • PSN $64.62
  • RGEN $143.56
  • Average True Range (ATR)
  • PSN 2.16
  • RGEN 7.12
  • MACD
  • PSN -0.19
  • RGEN -0.81
  • Stochastic Oscillator
  • PSN 45.49
  • RGEN 41.10

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: